 |
|
Solitary Colorectal Liver Metastasis
Resection Determines Outcome
Thomas A. Aloia, MD;
Jean-Nicolas Vauthey, MD;
Evelyne M. Loyer, MD;
Dario Ribero, MD;
Timothy M. Pawlik, MD, MPH;
Steven H. Wei, MS, PA-C;
Steven A. Curley, MD;
Daria Zorzi, MD;
Eddie K. Abdalla, MD
Arch Surg. 2006;141:460-467.
Background Hepatic resection (HR) and radiofrequency ablation (RFA) have been proposed as equivalent treatments for colorectal liver metastasis.
Hypothesis Recurrence patterns after HR and RFA for solitary liver metastasis are similar.
Design Analysis of a prospective database at a tertiary care center with systematic review of follow-up imaging in all of the patients.
Patients and Methods Patients with solitary liver metastasis as the first site of metastasis treated for cure by HR or RFA were studied (patients received no prior liver-directed therapy). Prognostic factors, recurrence patterns, and survival rates were analyzed.
Results Of the 180 patients who were studied, 150 underwent HR and 30 underwent RFA. Radiofrequency ablation was used when resection would leave an inadequate liver remnant (20 patients) or comorbidity precluded safe HR (10 patients). Tumor size and treatment determined recurrence and survival. The local recurrence (LR) rate was markedly lower after HR (5%) than after RFA (37%) (P<.001). Treatment by HR was associated with longer 5-year survival rates than RFA, including LR-free (92% vs 60%, respectively; P<.001), disease-free (50% vs 0%, respectively; P = .001), and overall (71% vs 27%, respectively; P<.001) survival rates. In the subset with tumors 3 cm or larger (n = 79), LR occurred more frequently following RFA (31%) than after HR (3%) (P = .001), with a 5-year LR-free survival rate of 66% after RFA vs 97% after HR (P<.001). Patients with small tumors experienced longer 5-year overall survival rates after HR (72%) as compared with RFA (18%) (P = .006).
Conclusions The survival rate following HR of solitary colorectal liver metastasis exceeds 70% at 5 years. Radiofrequency ablation for solitary metastasis is associated with a markedly higher LR rate and shorter recurrence-free and overall survival rates compared with HR, even when small lesions ( 3 cm) are considered. Every method should be considered to achieve resection of solitary colorectal liver metastasis, including referral to a specialty center, extended hepatectomy, and chemotherapy.
Author Affiliations: Departments of Surgical Oncology (Drs Aloia, Vauthey, Ribero, Pawlik, Curley, Zorzi, and Abdalla and Mr Wei) and Diagnostic Imaging (Dr Loyer), The University of Texas M. D. Anderson Cancer Center, Houston.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
Cheon et al.
Ann Oncol 2008;19:1146-1153.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Mulier et al.
Ann. Surg. Oncol. 2008;15:144-157.
ABSTRACT
| FULL TEXT
Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery
Park et al.
Ann. Surg. Oncol. 2008;15:227-232.
ABSTRACT
| FULL TEXT
Expanding Criteria for Resectability of Colorectal Liver Metastases
Pawlik et al.
The Oncologist 2008;13:51-64.
ABSTRACT
| FULL TEXT
Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group
Liersch et al.
Ann. Surg. Oncol. 2007;14:2577-2590.
ABSTRACT
| FULL TEXT
Role of Repeated Hepatectomy in the Multimodal Treatment of Hepatic Colorectal Metastases
Ahmad et al.
Arch Surg 2007;142:526-532.
ABSTRACT
| FULL TEXT
|
